NDAINTRAVENOUSSOLUTION
Approved
May 1983
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
2/8 — Basic
SODIUM ACETATE (sodium acetate) by Pfizer is clinical pharmacology sodium is the principal cation of extracellular fluid. First approved in 1983.
Drug data last refreshed 2d ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
Sodium acetate is an intravenous solution containing sodium and acetate ions used to manage electrolyte imbalances and metabolic acidosis in critical care settings. It functions by replenishing extracellular sodium (the principal cation) and providing acetate as a bicarbonate precursor metabolized primarily in the liver. The drug treats shock and ornithine transcarbamylase (OTC) deficiency by restoring electrolyte homeostasis and supporting acid-base balance.
LOE Approaching
As a legacy generic intravenous electrolyte product with LOE approaching, team size is typically minimal and focused on supply chain compliance rather than growth initiatives.
Mechanism of Action
CLINICAL PHARMACOLOGY Sodium is the principal cation of extracellular fluid. It comprises more than 90% of total cations at its normal plasma concentration of approximately 140 mEq/liter. The sodium ion exerts a primary role in controlling total body water and its distribution. Acetate (CH 3 COO)…
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on sodium acetate offers limited career upside given the product's mature, commoditized position and lack of commercial growth drivers. Roles are typically operational, compliance-focused, or supply-chain oriented rather than strategic or innovation-led, making this suitable for candidates prioritizing stability over advancement.
Supply Chain Manager
Worked on SODIUM ACETATE at Pfizer? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.